The United Kingdom’s stock market, as reflected by the FTSE 100, has recently faced downward pressure due to weak trade data from China, highlighting the interconnectedness of global economies and their impact on domestic indices. In such a climate, identifying stocks that may be trading below their estimated fair value can present opportunities for investors seeking potential upside in undervalued assets amidst broader market challenges.
Top 10 Undervalued Stocks Based On Cash Flows In The United Kingdom
|
Name |
Current Price |
Fair Value (Est) |
Discount (Est) |
|
Tristel (AIM:TSTL) |
£4.125 |
£7.63 |
45.9% |
|
Playtech (LSE:PTEC) |
£3.596 |
£6.70 |
46.3% |
|
Oxford Biomedica (LSE:OXB) |
£6.18 |
£12.25 |
49.5% |
|
Mitie Group (LSE:MTO) |
£1.731 |
£3.40 |
49.2% |
|
Marks and Spencer Group (LSE:MKS) |
£3.202 |
£6.18 |
48.2% |
|
Fevertree Drinks (AIM:FEVR) |
£7.78 |
£14.94 |
47.9% |
|
Entain (LSE:ENT) |
£5.324 |
£10.06 |
47.1% |
|
Convatec Group (LSE:CTEC) |
£2.08 |
£4.14 |
49.8% |
|
B90 Holdings (AIM:B90) |
£0.023 |
£0.045 |
49.4% |
|
Advanced Medical Solutions Group (AIM:AMS) |
£2.47 |
£4.87 |
49.3% |
Underneath we present a selection of stocks filtered out by our screen.
Cohort
Overview: Cohort plc operates in the defense, security, and related markets across multiple regions including the United Kingdom, Germany, Portugal, Australia, the Americas, Asia Pacific, Africa, and Europe with a market cap of £514.85 million.
Operations: The company’s revenue is primarily derived from its Sensors and Effectors segment, generating £147.78 million, and its Communications and Intelligence segment, contributing £132.04 million.
Estimated Discount To Fair Value: 10.1%
Cohort is trading below its estimated future cash flow value (£12.5) at £11.24, indicating it may be undervalued based on cash flows. Analysts expect earnings to grow significantly at 20.23% annually, outpacing the UK market’s 11.9%. Despite a low forecasted Return on Equity of 15.5%, Cohort’s revenue growth (7.2%) surpasses the market average (4.5%). Recent contract wins, such as a €42.3 million deal with the Portuguese Navy, bolster its financial outlook.
National Atomic Company Kazatomprom JSC
Overview: National Atomic Company Kazatomprom JSC is involved in the exploration, production, processing, marketing, and sale of uranium and related products with a market cap of $18.69 billion.
Operations: The company’s revenue primarily comes from its Uranium segment, generating KZT 1.64 trillion, and the UMP segment, contributing KZT 90.64 billion.
